$OABIW SEC Filings

Filed On	Filing
14 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	Form 4: Nwachuku Amechi Ekeke, Chief Operating Officer Granted 800,000 Stock Option (right to buy)
13 Jul 2026	Form 3: Nwachuku Amechi Ekeke, Chief Operating Officer No securities owned
13 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
18 Jun 2026	Form 4: Cochran Jennifer R., Director Received 20,000 shares by exercise or conversion · Granted 20,000 Restricted Stock Units · Granted 40,000 Stock Option (right to buy)
18 Jun 2026	Form 4: Crouse Steven C., Director Received 20,000 shares by exercise or conversion · Granted 20,000 Restricted Stock Units · Granted 40,000 Stock Option (right to buy)
18 Jun 2026	Form 4: Bertozzi Carolyn R, Director Received 20,000 shares by exercise or conversion · Granted 20,000 Restricted Stock Units · Granted 40,000 Stock Option (right to buy)
18 Jun 2026	Form 4: Gotwals Philip J, Director Received 20,000 shares by exercise or conversion · Granted 20,000 Restricted Stock Units · Granted 40,000 Stock Option (right to buy)
18 Jun 2026	Form 4: Higgins John L, Director Received 20,000 shares by exercise or conversion · Granted 20,000 Restricted Stock Units · Granted 40,000 Stock Option (right to buy)
18 Jun 2026	Form 4: Love Steven, Director Received 20,000 shares by exercise or conversion · Granted 20,000 Restricted Stock Units · Granted 40,000 Stock Option (right to buy)
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
29 Apr 2026	ARS
29 Apr 2026	DEFA14A
29 Apr 2026	Proxy statement: annual meeting on June 17, 2026
21 Apr 2026	Form 4: Gotwals Philip J, Director Received 13,333 shares by exercise or conversion
21 Apr 2026	Form 4: Crouse Steven C., Director Received 13,333 shares by exercise or conversion

Comments